RSK
RSK (ribosomal s6 kinase) is a family of protein kinases involved in signal transduction.
Products Related to RSK(33)
- GC62675SM1-71CAS: 2088179-99-9Purity: >98%
SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC50294 | RMM 46 | 1307896-46-3 | >98% | |
MSK/RSK family kinase inhibitor | ||||
| GC61941 | Eudesmin | 526-06-7 | >99.00% | |
Eudesmin ((-)-Eudesmin) impairs adipogenic differentiation via inhibition of S6K1 signaling pathway. | ||||
| GC62675 | SM1-71 | 2088179-99-9 | >98% | |
SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines. | ||||
| GC72910 | DD1 | 187585-11-1 | >99.00% | |
DD1, a proteasome inhibitor, targets Bax activation and P70S6K degradation during acute myeloid leukemia (AML) apoptosis. | ||||
| GC73030 | RSK4-IN-1 TFA | - | - | |
RSK4-IN-1 TFA is a potent RSK4 inhibitor with a IC50 value of 9.5 nM. | ||||
| GC73727 | TAS0612 | 2148902-58-1 | >98.00% | |
TAS0612 is an orally novel inhibitor of RSK、AKT and S6K. | ||||
| GC80870 | XL-418 | 871343-09-8 | >95.00% | |
XL-418 is an orally active dual Akt and p70S6K inhibitor with IC 50 s of 1 nM for Akt1 and 2 nM for p70S6K. | ||||
| GN10016 | Carnosol | 5957-80-2 | >98.00% | |
| GN10814 | Quercitrin | 522-12-3 | >98.00% | |
